Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Vaccine|May 17, 2006
Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12Mark A Jacobson, Elizabeth Sinclair, Barry Bredt, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2008
Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDSMark A Jacobson, Qi Xuan Tan, Valerie Girling, et al.AIDS (London, England)|February 27, 2016
Human papillomavirus infection in the oral cavity of HIV patients is not reduced by initiating antiretroviral therapyCaroline H Shiboski, Anthony Lee, Huichao Chen, et al.Journal of Occupational and Environmental Medicine|December 31, 2024
Rapid COVID-19 Testing of Symptomatic Health Care Personnel: A Strategy for Safely Maintaining the WorkforceMonica K Tilly, James E McNicholas, Jeffrey D Whitman, et al.The Journal of Infectious Diseases|November 4, 2006
Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotypeElizabeth Sinclair, Qi Xuan Tan, Margaret Sharp, et al.Antimicrobial Agents and Chemotherapy|August 17, 2002
Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV sheddingJacob P Lalezari, Judith A Aberg, Laurene H Wang, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2014
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDSAdriana Weinberg, Ronald Bosch, Kara Bennett, et al.Plos One|November 22, 2013
The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefitDavid A Wohl, Michelle A Kendall, Judith Feinberg, et al.European Cytokine Network|June 28, 2007
Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjectsGregory B Pott, Carrie A Sailer, Reuven Porat, et al.Journal of Immunological Methods|August 21, 2007
Loss of T cell responses following long-term cryopreservationRachel E Owen, Elizabeth Sinclair, Brinda Emu, et al.Pageof 4